TPG is in a sustained, broad downtrend: the stock is down 22.51% over the past year and 35.33% year-to-date, with a maximum drawdown of -45.55% from its peak. At $42.52, the shares sit at roughly 16.6% of the 52-week range of $36.95 to $70.38 — deep in the lower quartile and only about 15% above the 52-week low. That positioning signals a falling-knife profile rather than a momentum setup, though the proximity to the low also creates a defined risk point for contrarian buyers. Relative strength confirms the weakness: TPG has underperformed SPY by 38.04 percentage points over one year and 47.26 points year-to-date, a persistent and severe lag that argues against calling this a mere pullback.\n\nShort-term momentum is deteriorating again after a summer rally. The stock is down 8.66% over the past month versus a +1.22% gain for SPY (a -9.88 point relative-strength spread), and down 2.79% over three months against SPY's +2.69%. The one-month decline directly conflicts with the June-to-August recovery that carried shares from a $38.74 low on June 24 to a $55.21 peak on August 13 — a roughly 42% rebound that has now been more than half retraced, with the price falling from $55.21 to $42.52. This divergence between the intermediate recovery and the renewed one-month slide suggests the August rally was a counter-trend bounce rather than a trend reversal, and the failure to hold the $50 area is a bearish tell. Volume of roughly 3.79 million shares and a short ratio of 5.36 days indicate meaningful short interest that could amplify moves in either direction.\n\nKey technical levels are well defined. Support sits at the 52-week low of $36.95, roughly 13% below the current $42.52; a breakdown there would confirm the primary downtrend and likely trigger momentum-driven selling. Resistance is anchored at the 52-week high of $70.38, but the more actionable near-term resistance is the August high of $55.21, followed by the $50 round number that has already rejected twice. A reclaim of $50 would be the first evidence of a durable bottom; a break of $36.95 would signal capitulation. With a beta of 1.473, TPG is roughly 47% more volatile than the market, meaning position sizing should be scaled down accordingly — a 10% market move implies roughly a 15% move in TPG, and the -45.55% max drawdown illustrates the downside tail in practice.

Revenue is lumpy and driven by performance allocations rather than a smooth fee base. Q2 2026 revenue was $1.841 billion, up 1.65% year-over-year from $696 million in Q2 2025 — but that comparison is distorted by the $1.113 billion of performance allocations booked in Q2 2026 versus a much smaller carried-interest contribution a year earlier. Sequentially, revenue collapsed from $1.491 billion in Q4 2025 to just $496 million in Q1 2026 before rebounding to $1.841 billion, a pattern that reflects mark-to-market swings in the portfolio rather than operating deterioration. Within the segment mix, management fees of $522.7 million are the stable recurring base, while performance allocations of $1.113 billion dwarfed transaction fees ($97.2 million), monitoring fees ($7.0 million), and incentive fees ($8.95 million) in the reported period. The investment case therefore hinges on whether fee-related earnings can grow fast enough to smooth the carried-interest volatility; the 1.65% headline growth rate is modest for an alternatives manager and suggests fundraising and deployment are not yet accelerating.\n\nProfitability is positive but highly uneven. Q2 2026 net income was $93.4 million on a 5.07% net margin, with a gross margin of 98.03% and an operating margin of 22.90% — the latter inflated by the carried-interest quarter. Q1 2026 swung to a net loss of $1.45 million (net margin -0.29%) with a negative operating margin of -24.25%, while Q4 2025 delivered $77.1 million of net income at a 5.17% margin. The trailing figures — net margin of 3.95%, operating margin of 14.68%, and EPS of $0.02 — show how thin the through-cycle profitability is once the performance-fee spikes are averaged out. For an asset manager, a high-90s gross margin is structurally normal (there is little cost of revenue), so the real test is operating leverage on the fee base; the 22.9% Q2 operating margin is respectable but the negative Q1 print shows how quickly it evaporates when markets mark portfolios down.\n\nThe balance sheet carries meaningful leverage and a liquidity profile that requires careful reading. Debt-to-equity stands at 1.45x, with total debt to capitalization of 70.7% and long-term debt to capitalization of 65.5% — elevated for an asset manager and a key risk if fundraising slows. Free cash flow is strong on a trailing basis at $917.5 million, and Q2 2026 alone generated $328.2 million of FCF on $347.7 million of operating cash flow, but the quarterly series is volatile (Q4 2025 FCF was -$53.0 million). ROE of 15.57% and ROA of 5.22% are healthy, and the firm returned capital aggressively — $256.6 million of dividends paid and $209.0 million of buybacks in Q2 2026 — while holding $957.8 million of cash. The current ratio of 0.153 is a red flag for near-term liquidity on the balance sheet, though for a financial firm with substantial investment assets this metric is less meaningful than the FCF generation and the $917 million TTM cash flow, which comfortably covers the dividend and buyback program.